Literature DB >> 19219656

Cross-talk between Notch and EGFR signaling in human breast cancer cells.

Jianjian Dai1, Daoxin Ma, Shaolei Zang, Dongmei Guo, Xun Qu, Jingjing Ye, Chunyan Ji.   

Abstract

Notch and epidermal growth factor receptor (EGFR) signaling play critical roles in cell proliferation, differentiation, and apoptosis, and thereby may contribute to the development of breast cancer. We constitutively overexpressed active Notch1 in human breast cancer cells to explore the consequences of Notch1 signaling on cell growth and to investigate the underlying molecular mechanisms. We found that EGFR expression was increased. Then, using EGFR inhibitor, we found it exhibited an inhibitory role on human breast cancer cells. Overexpression of Notch1 could reverse EGFR inhibitor-induced cell toxicity, suggesting that Notch and EGFR signaling may be positively cross-linked in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219656     DOI: 10.1080/07357900802563036

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  17 in total

1.  Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.

Authors:  Yang Zheng; Zhao Wang; Xu Ding; Yibo Dong; Wei Zhang; Wei Zhang; Yi Zhong; Wenyi Gu; Yunong Wu; Xiaomeng Song
Journal:  Cell Prolif       Date:  2017-12-12       Impact factor: 6.831

Review 2.  Role of Notch and its oncogenic signaling crosstalk in breast cancer.

Authors:  Shanchun Guo; Mingli Liu; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-12-28

Review 3.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.

Authors:  Naoko Takebe; Pamela J Harris; Ronald Q Warren; S Percy Ivy
Journal:  Nat Rev Clin Oncol       Date:  2010-12-14       Impact factor: 66.675

4.  Notch signaling: a hero or villain in the war against cancer?

Authors:  Shireen Chikara; Katie M Reindl
Journal:  Transl Lung Cancer Res       Date:  2013-12

5.  An alternative way to initiate Notch1 signaling in non-small cell lung cancer.

Authors:  Yi-Lin Yang; David Jablons; Liang You
Journal:  Transl Lung Cancer Res       Date:  2014-08

Review 6.  Targeting Notch signaling pathway to overcome drug resistance for cancer therapy.

Authors:  Zhiwei Wang; Yiwei Li; Aamir Ahmad; Asfar S Azmi; Sanjeev Banerjee; Dejuan Kong; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-06-22

Review 7.  New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers.

Authors:  Armel Hervé Nwabo Kamdje; Paul Faustin Seke Etet; Lorella Vecchio; Richard Simo Tagne; Jeremie Mbo Amvene; Jean-Marc Muller; Mauro Krampera; Kiven Erique Lukong
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

Review 8.  Epidermal growth factor signaling in transformed cells.

Authors:  Stephan Lindsey; Sigrid A Langhans
Journal:  Int Rev Cell Mol Biol       Date:  2014-11-18       Impact factor: 6.813

9.  Gamma Secretase Inhibition by BMS-906024 Enhances Efficacy of Paclitaxel in Lung Adenocarcinoma.

Authors:  Katherine M Morgan; Bruce S Fischer; Francis Y Lee; Jamie J Shah; Joseph R Bertino; Jeffrey Rosenfeld; Amartya Singh; Hossein Khiabanian; Sharon R Pine
Journal:  Mol Cancer Ther       Date:  2017-10-04       Impact factor: 6.261

Review 10.  Regulation of angiogenesis via Notch signaling in breast cancer and cancer stem cells.

Authors:  Weiqiang Zhou; Guangdi Wang; Shanchun Guo
Journal:  Biochim Biophys Acta       Date:  2013-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.